Severe Solar Maculopathy Associated with the use of Lysergic Acid Diethylamide (LSD)
American Journal of Ophthalmology April 1, 1976 DOI: 10.1016/0002-9394(76)90295-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 23-year-old man |
| Topics | LSD |
| Keywords | Maculopathy Retinal pigment epithelium Fundus photography Fluorescein angiography Lipofuscin Ophthalmology Fundus uterus Hallucinogen Drug-induced ocular toxicity |
| Citations | 52 |
| Key findings | Sun gazing during a hallucinogenic drug-induced state caused severe macular damage with prominent focal injury to the retinal pigment epithelium. |
Abstract
A 23-year-old man sustained severe macular damage by sun gazing during a hallucinogenic drug-induced state. Sequential fundus photography and fluorescein angiography documented prominent focal injury to the retinal pigment epithelium.
Comparable studies
Other case reports and case series on LSD, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Lasting Neuropsychiatric Sequelae of (??)Methylenedioxymethamphetamine (???Ecstasy???) in Recreational Users Persons who ingested large doses of MDMA | 1991 | Case study | n = 2 |
| Further Studies in the Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness Patients with mental illness | 1957 | Case series | |
| Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose a Report of Eight Cases People who self-administered large amounts of pure LSD powder intranasally | 1975 | Case series | n = 8 |
| Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders Patients with chronic complex post-traumatic stress disorder (c-PTSD), dissociative,... | 2022 | Case series | |
| Persistent Palinopsia Following Ingestion of Lysergic Acid Diethylamide (LSD) Patients who developed persistent palinopsia after LSD ingestion | 1996 | Case series | n = 3 |
Citations in the library
Cited by 3
- Perceived Risk of Trying Lysergic Acid Diethylamide in the United States from 2015 to 2019: Are Americans Assessing Lysergic Acid Diethylamide's Risk Profile More Favorably? Psychedelic Medicine June 1, 2024
- The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication. Trends in Psychiatry and Psychotherapy 2025
- Hallucinogens. Pharmacology & Therapeutics February 1, 2004